 NEW YORK, May 20, 2021 PRNewswire -- AIkido Pharma Inc. Nasdaq: AIKI AIkido or the Company today announced that Phase 1 testing data will be presented at the 2021 ASCO Annual Meeting June 4, 2021. The presentation of the data will be by Dr. Scott Tagawa, a Professor of Medicine Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. 